Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
UCLA Depression Research and Clinic Program
1982
mi
from 43215
Los Angeles, CA
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
UCLA Depression Research and Clinic Program
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Hartford Hospital- The Institute of Living
554
mi
from 43215
Hartford, CT
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Hartford Hospital- The Institute of Living
554
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
TMS Specialists Chicago
274
mi
from 43215
Chicago, IL
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
TMS Specialists Chicago
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Sheppard Pratt Health System
343
mi
from 43215
Baltimore, MD
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Sheppard Pratt Health System
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Univ of Nebraska Med Ctr
682
mi
from 43215
Omaha, NE
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Univ of Nebraska Med Ctr
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Center for Mood Disorders and Neuromodulation Therapies, UMDNJ-SOM
423
mi
from 43215
Cherry Hill, NJ
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Center for Mood Disorders and Neuromodulation Therapies, UMDNJ-SOM
423
mi
from 43215
Cherry Hill, NJ
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Duke University Brain Stimulation and Neurophysiology Center
354
mi
from 43215
Durham, NC
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Duke University Brain Stimulation and Neurophysiology Center
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Mood Disorders Treatment Research Program University of Pittsburgh-Western Psychiatric Institute and Clinic
162
mi
from 43215
Pittsburgh, PA
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Mood Disorders Treatment Research Program University of Pittsburgh-Western Psychiatric Institute and Clinic
162
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Butler Hospital Mood Disorders Research Program, Brown Department of Psychiatry and Human Behavior
619
mi
from 43215
Providence, RI
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Butler Hospital Mood Disorders Research Program, Brown Department of Psychiatry and Human Behavior
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
MUSC Institute of Psychiatry, Brain Stimulation Lab
525
mi
from 43215
Charleston, SC
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
MUSC Institute of Psychiatry, Brain Stimulation Lab
525
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
U.T. Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
U.T. Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
R/D Clinical Research, Inc.
1032
mi
from 43215
Lake Jackson, TX
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
R/D Clinical Research, Inc.
1032
mi
from 43215
Lake Jackson, TX
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
UCSD Medical Center
1950
mi
from 43215
San Diego, CA
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
UCSD Medical Center
1950
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
UCLA Harbor
1980
mi
from 43215
Torrance, CA
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
UCLA Harbor
1980
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Washington University School of Medicine
397
mi
from 43215
St. Louis, MO
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Washington University School of Medicine
397
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Mount Sinai School of Medicine
481
mi
from 43215
New York, NY
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Mount Sinai School of Medicine
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Wake Forest University Medical Center
306
mi
from 43215
Winston Salem, NC
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Wake Forest University Medical Center
306
mi
from 43215
Winston Salem, NC
Click here to add this to my saved trials
Complex Dynamic Systems in Mood Disorders
Complex Dynamic Systems in Mood Disorders
Status: Enrolling
Updated:  10/5/2015
Bipolar Clinic and Research Program at Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Complex Dynamic Systems in Mood Disorders
Complex Dynamic Systems in Mood Disorders
Status: Enrolling
Updated: 10/5/2015
Bipolar Clinic and Research Program at Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Pacific Clinical Research Medical Group
1960
mi
from 43215
Arcadia, CA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Pacific Clinical Research Medical Group
1960
mi
from 43215
Arcadia, CA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Artemis Institute for Clinical Research
1947
mi
from 43215
San Diego, CA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Artemis Institute for Clinical Research
1947
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
California Neuroscience Research Medical Group, Inc
1981
mi
from 43215
Sherman Oaks, CA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
California Neuroscience Research Medical Group, Inc
1981
mi
from 43215
Sherman Oaks, CA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Gulfcoast Clinical Research Center
932
mi
from 43215
Fort Myers, FL
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Gulfcoast Clinical Research Center
932
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Clinical Neuroscience Solutions, Inc.
673
mi
from 43215
Jacksonville, FL
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Clinical Neuroscience Solutions, Inc.
673
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Florida Clinical Research Center LLC
788
mi
from 43215
Maitland, FL
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Florida Clinical Research Center LLC
788
mi
from 43215
Maitland, FL
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Clinical Neurosciences Solutions
795
mi
from 43215
Orlando, FL
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Clinical Neurosciences Solutions
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Stedman Clinical Trials
821
mi
from 43215
Tampa, FL
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Stedman Clinical Trials
821
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Carman Research
428
mi
from 43215
Smyrna, GA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Carman Research
428
mi
from 43215
Smyrna, GA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Goldpoint Clinical Research
167
mi
from 43215
Indianapolis, IN
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Goldpoint Clinical Research
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Pharmasite Research
337
mi
from 43215
Baltimore, MD
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Pharmasite Research
337
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Clinical Insights Inc
344
mi
from 43215
Glen Burnie, MD
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Clinical Insights Inc
344
mi
from 43215
Glen Burnie, MD
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Rochester Center for Behavioral Medicine
186
mi
from 43215
Rochester Hills, MI
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Rochester Center for Behavioral Medicine
186
mi
from 43215
Rochester Hills, MI
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Center for Psychiatry and Behavioral Medicine, Inc.
1762
mi
from 43215
Las Vegas, NV
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Center for Psychiatry and Behavioral Medicine, Inc.
1762
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Center For Emotional Fitness
424
mi
from 43215
Cherry Hill, NJ
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Center For Emotional Fitness
424
mi
from 43215
Cherry Hill, NJ
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Brooklyn Medical Institute
477
mi
from 43215
Brooklyn, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Brooklyn Medical Institute
477
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Medical & Behavioral Health Research
478
mi
from 43215
New York, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Medical & Behavioral Health Research
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
The Medical Research Network, LLC
480
mi
from 43215
New York, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
The Medical Research Network, LLC
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Finger Lakes Clinical Research
356
mi
from 43215
Rochester, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Finger Lakes Clinical Research
356
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Midwest Clinical Research Center
65
mi
from 43215
Dayton, OH
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Midwest Clinical Research Center
65
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Oregon Center for Clinical Investigations, Inc.
2028
mi
from 43215
Portland, OR
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Oregon Center for Clinical Investigations, Inc.
2028
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Oregon Center for Clinical Investigations, Inc
2045
mi
from 43215
Salem, OR
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Oregon Center for Clinical Investigations, Inc
2045
mi
from 43215
Salem, OR
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Carolina Clinical Research Services
426
mi
from 43215
Columbia, SC
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Carolina Clinical Research Services
426
mi
from 43215
Columbia, SC
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
FutureSearch Trials of Dallas
905
mi
from 43215
Dallas, TX
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
FutureSearch Trials of Dallas
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Bayou City Research, Ltd.
996
mi
from 43215
Houston, TX
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Bayou City Research, Ltd.
996
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Radiant Research, Inc.
1516
mi
from 43215
Murray, UT
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Radiant Research, Inc.
1516
mi
from 43215
Murray, UT
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Psychiatric Alliance of The Blue Ridge
275
mi
from 43215
Charlottesville, VA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Psychiatric Alliance of The Blue Ridge
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
NeuroScience, Inc.
308
mi
from 43215
Herndon, VA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
NeuroScience, Inc.
308
mi
from 43215
Herndon, VA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Northwest Clinical Research Center
1998
mi
from 43215
Bellevue, WA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Northwest Clinical Research Center
1998
mi
from 43215
Bellevue, WA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Summit Research Network LLC
2006
mi
from 43215
Seattle, WA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Summit Research Network LLC
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Northbrooke Research Center
338
mi
from 43215
Brown Deer, WI
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Northbrooke Research Center
338
mi
from 43215
Brown Deer, WI
Click here to add this to my saved trials